Publications de Christel PROTIERE
Primary tabs
Perception of PrEP-related stigma in PrEP users: Results from the ANRS-PREVENIR cohort.
HIV Medicine
2023
;
24
:
938 - 945.
Impact of HIV risk perception on both pre-exposure prophylaxis and condom use.
Journal of Health Psychology
2021
;
26
(10)
:
1575-1586.
Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS‐APSEC study: a discrete choice experiment.
Journal of the International AIDS Society
2020
;
23
(2)
:
e25443.
What are the situational and behavioral factors associated with condomless anal sex without pre-exposure prophylaxis in MSM?
AIDS. Official journal of the international AIDS Society
2020
;
34
(9)
:
1367-1375.
Who are the PLWH who might refuse to participate in HIV cure-related clinical trials with treatment interruption?
AIDS. Official journal of the international AIDS Society
2020
;
1.
What is the effect of self-identified HIV activism in willingness to participate in HIV cure-related clinical trials? Results from the ANRS-APSEC study.
Journal of Virus Eradication
2019
;
5
(3)
:
152-162.
The ANRS-Ipergay trial, an opportunity to use qualitative research to understand the perception of the “participant”-physician relationship.
AIDS Care
2018
;
30
(sup2)
:
41-47.
Importance of the patient-physician interaction in assessing acceptability of HIV cure trials.
HIV Medicine
2018
;
19
(4)
:
e56-e57.
Acceptability of HIV cure-related trials: the challenges for physicians and people living with HIV (ANRS-APSEC).
AIDS Care
2018
;
30
(7)
:
914-920.
Will CURE trials introduce an uncomfortable revolution in the field of HIV research?
HIV Clinical Trials
2017
;
18
(4)
:
174-175.
https://www.tandfonline.com/doi/full/10.1080/15284336.2017.1331603
How Can Contingent Valuation Inform the Bioethics Debate? Evidence from a Survey on Hereditary Cancers in France.
Revue Economique
2017
;
68
(3)
:
379--404.
Take the Money and Run? Hypothetical Fee Variations and French GPs’ Labour Supply.
Revue Economique
2017
;
68
(3)
:
357--377.
Cost-effectiveness of adjuvant docetaxel for node-positive breast cancer patients: results of the PACS 01 economic study.
Annals of Oncology
2010
;
21
(7)
:
1448-1454.
Eliciting several willingness to pay in a single contingent valuation survey: application to health care.
Health Economics
2003
;
12
(1)
:
51-64.
Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
Supportive Care in Cancer
2002
;
10
(7)
:
529-537.
Quality of life of breast cancer patients receiving high-dose-intensity chemotherapy: impact of length of cycles.
Supportive Care in Cancer
2002
;
10
(3)
:
222-230.
Evaluation économétrique du coût d'une allogreffe de moelle osseuse.
Journal d'Economie Médicale
1996
;
14
(6)
:
323-331.